Compound: BI-2536

Drug Target: PLK1, PLK2, PLK3

Drug Target pathway: Cell cycle

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.